newsfilter
← Latest News
GlobeNewswire·

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

KA

SEATTLE, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance,